ArticleEuropean journal of medical research2022

COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.

Shiwei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.